• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从基线18F FDG PET/CT成像中得出的影像组学特征可预测原发性乳腺癌患者的肿瘤浸润淋巴细胞值。

Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.

作者信息

Vural Topuz Özge, Bağbudar Sidar, Aksu Ayşegül, Söylemez Akkurt Tuçe, Akkaş Burcu Esen

机构信息

Department of Nuclear Medicine, Başakşehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.

Department of Pathology, Başakşehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

Nuklearmedizin. 2025 Jun;64(3):194-204. doi: 10.1055/a-2512-8212. Epub 2025 Jan 28.

DOI:10.1055/a-2512-8212
PMID:39875129
Abstract

To determine the value of radiomics data extraction from baseline 18F FDG PET/CT in the prediction of tumor-infiltrating lymphocytes (TILs) among patients with primary breast cancer (BC).We retrospectively evaluated 74 patients who underwent baseline 18F FDG PET/CT scans for BC evaluation between October 2020 and April 2022. Radiomics data extraction resulted in a total of 131 radiomic features from primary tumors. TILs status was defined based on histological analyses of surgical specimens and patients were categorized as having low TILs or moderate & high TILs. The relationships between TILs groups and tumor features, patient characteristics and molecular subtypes were examined. Features with a correlation coefficient of less than 0.6 were analyzed by logistic regression to create a predictive model. The diagnostic performance of the model was calculated via receiver operating characteristics (ROC) analysis.Menopausal status, histological grade, nuclear grade, and four radiomics features demonstrated significant differences between the two TILs groups. Multivariable logistic regression revealed that nuclear grade and three radiomics features (Morphological COMShift, GLCM Correlation, and GLSZM Small Zone Emphasis) were independently associated with TIL grouping. The diagnostic performance analysis of the model showed an AUC of 0.864 (95% CI: 0.776-0.953; p < 0.001). The sensitivity, specificity, PPV, NPV and accuracy values of the model were 69.6%, 82.4%, 64%, 85.7% and 78.4%, respectivelyThe pathological TIL scores of BC patients can be predicted by using radiomics feature extraction from baseline 18F FDG PET/CT scans.

摘要

为了确定从基线18F FDG PET/CT中提取的影像组学数据在预测原发性乳腺癌(BC)患者肿瘤浸润淋巴细胞(TILs)方面的价值。我们回顾性评估了2020年10月至2022年4月期间接受基线18F FDG PET/CT扫描以评估BC的74例患者。影像组学数据提取共产生了来自原发性肿瘤的131个影像组学特征。TILs状态基于手术标本的组织学分析来定义,患者被分类为低TILs或中高TILs。研究了TILs组与肿瘤特征、患者特征和分子亚型之间的关系。对相关系数小于0.6的特征进行逻辑回归分析以创建预测模型。通过受试者操作特征(ROC)分析计算模型的诊断性能。绝经状态、组织学分级、核分级和四个影像组学特征在两个TILs组之间表现出显著差异。多变量逻辑回归显示核分级和三个影像组学特征(形态学COMShift、灰度共生矩阵相关性和灰度游程长度矩阵小区域强调)与TIL分组独立相关。模型的诊断性能分析显示AUC为0.864(95%CI:0.776 - 0.953;p < 0.001)。模型的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为69.6%、82.4%、64%、85.7%和78.4%。通过从基线18F FDG PET/CT扫描中提取影像组学特征可以预测BC患者的病理TIL评分。

相似文献

1
Radiomic signatures derived from baseline 18F FDG PET/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer.从基线18F FDG PET/CT成像中得出的影像组学特征可预测原发性乳腺癌患者的肿瘤浸润淋巴细胞值。
Nuklearmedizin. 2025 Jun;64(3):194-204. doi: 10.1055/a-2512-8212. Epub 2025 Jan 28.
2
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.基于治疗前鼻咽部 [18F]FDG PET/CT 图像的放射组学分析预测局部复发和远处转移。
Ann Nucl Med. 2021 Apr;35(4):458-468. doi: 10.1007/s12149-021-01585-9. Epub 2021 Feb 4.
3
F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients.F-FDG PET/CT影像组学分析及人工智能预测乳腺癌患者新辅助化疗后的病理完全缓解
Radiol Med. 2025 Apr;130(4):543-554. doi: 10.1007/s11547-025-01958-4. Epub 2025 Jan 28.
4
A different perspective on F-FDG PET radiomics in colorectal cancer patients: The relationship between intra & peritumoral analysis and pathological findings.结直肠癌患者 F-FDG PET 影像组学的另一种视角:肿瘤内及肿瘤周围分析与病理发现之间的关系。
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 Nov-Dec;42(6):359-366. doi: 10.1016/j.remnie.2023.04.005. Epub 2023 Apr 23.
5
Application of 18F-FDG PET/CT imaging radiomics in the differential diagnosis of single-nodule pulmonary metastases and second primary lung cancer in patients with colorectal cancer.18F-FDG PET/CT 影像组学在结直肠癌单发肺转移与第二原发肺癌鉴别诊断中的应用
J Cancer Res Ther. 2024 Apr 1;20(2):599-607. doi: 10.4103/jcrt.jcrt_1674_23. Epub 2024 Apr 30.
6
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.基于[18F]-FDG 的 PET/CT 与 PET/MR 影像中影像组学特征的可互换性。
Med Phys. 2019 Apr;46(4):1677-1685. doi: 10.1002/mp.13422. Epub 2019 Feb 22.
7
Can we skip invasive biopsy of sentinel lymph nodes? A preliminary investigation to predict sentinel lymph node status using PET/CT-based radiomics.能否跳过前哨淋巴结的有创活检?使用基于 PET/CT 的放射组学预测前哨淋巴结状态的初步研究。
BMC Cancer. 2024 Oct 25;24(1):1316. doi: 10.1186/s12885-024-13031-w.
8
Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics.应用 18F-FDG PET/CT 影像组学和临床病理特征评估乳腺癌患者的雄激素受体表达。
BMC Med Imaging. 2023 Jul 17;23(1):93. doi: 10.1186/s12880-023-01052-z.
9
Molecular subtype classification of breast cancer using established radiomic signature models based on F-FDG PET/CT images.基于 F-FDG PET/CT 图像的放射组学特征模型对乳腺癌进行分子亚型分类。
Front Biosci (Landmark Ed). 2021 Aug 30;26(9):475-484. doi: 10.52586/4960.
10
Applying deep learning-based ensemble model to [F]-FDG-PET-radiomic features for differentiating benign from malignant parotid gland diseases.将基于深度学习的集成模型应用于[F]-FDG-PET放射组学特征,以鉴别腮腺良性和恶性疾病。
Jpn J Radiol. 2025 Jan;43(1):91-100. doi: 10.1007/s11604-024-01649-6. Epub 2024 Sep 10.

引用本文的文献

1
Are [18F]FDG PET/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?[18F]FDG PET/CT成像和血细胞计数衍生的生物标志物能否作为早期乳腺癌肿瘤浸润淋巴细胞的可靠非侵入性替代指标?
Ann Nucl Med. 2025 Aug 12. doi: 10.1007/s12149-025-02098-5.